Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,183.56, giving the company a market capitalization of 1.11T. It carries a P/E multiple of 40.16 and pays a dividend yield of 0.57%.
On 2026-09-25, Eli Lilly(LLY) stock traded between a low of $1,160.84 and a high of $1,190.00. Shares are currently priced at $1,183.56, which is +2.0% above the low and -0.5% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.92M, compared to an average daily volume of 2.33M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Eli Lilly (LLY) and Company announced that the U.S. FDA approved Olumiant, a once-daily pill, for the treatment of pediatric patients 12 years of age and older...
...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. The phase 3 ADVANCE-SURMOUNT-KIDS study, officially titled “Efficacy, Safety,...
Analyst ratings
84%
of 32 ratingsMore LLY News
A federal jury in California has awarded Nektar Therapeutics Inc. (NASDAQ:NKTR) $90 million in damages, finding that Eli Lilly and Co. (NYSE:LLY) breached the i...
Nektar Therapeutics ( (NKTR) ) has issued an announcement. In August 2023, Nektar Therapeutics filed a complaint in the U.S. District Court for the Northern Di...
Key Points Novo this week laid out an ambitious strategy to reignite growth beyond its top-selling Wegovy and Ozempic injections, but faces an uphill battle to...
Eli Lilly (LLY) just secured U.S. FDA approval for Onswik, a once weekly basal insulin for adults with type 2 diabetes, an update that quickly drew investor att...
Choosing between AbbVie (ABBV +0.01%) and Eli Lilly and Co (LLY +2.69%) requires weighing established income against explosive growth. Both companies lead the p...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company is running a new observational study in the U.A.E. that...
On Thursday, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Co.’s (NYSE:LLY) Onswik (insulin efsitora alfa-gobe), a once-weekly basal insuli...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.